Through its multiple interactions with its specific AT1 receptor, angiotensin II (Ang II), the major active product of this system synthesized both systemically and within the kidney, is a mediator of progressive injury in diabetic nephropathy. Here, AGTR1 is linked to diabetic kidney disease.